Professional Documents
Culture Documents
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Plaintiff Applied Medical Resources Corporation for its Complaint states and alleges as follows: PARTIES 1. Plaintiff Applied Medical Resources Corporation (Applied) is a
corporation incorporated under the laws of California and has its principal place of business at 22872 Avenida Empresa, Rancho Santa Margarita, California 92677, in Orange County, California. 2. Upon information and belief, Defendant Tyco Healthcare Group
LP (Defendant) is a Delaware limited partnership, doing business as Covidien, and having a principle place of business at 15 Hampshire Street, Mansfield, Massachusetts 02048. JURISDICTION AND VENUE 3. This is an action for patent infringement arising under the Patent
Laws of the United States (Title 35 of the United States Code). 4. 5. The Court has jurisdiction under 28 U.S.C. 1331 and 1338(a). Venue lies in this district under 28 U.S.C. 1391(b) and (c) and
1400(b) in that Defendant has committed acts of infringement in this district. Venue is proper in the Southern Division of this district under the provisions of General Order 349-A (1)(A) in light of the facts that: 1) plaintiff Applied is resident in the Southern Division, 2) Defendant resides in a place outside the Central District of California, and 3) either the claim for patent infringement arose in the Southern Division where Applied has been injured by Defendants infringement or the majority of claims for patent infringement arose outside the Central District of California where Defendant has committed the majority of its acts of infringement. THE PATENT-IN-SUIT 6. Applied is the owner by assignment of U.S. Patent No. 8,016,755
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
patent) which issued September 13, 2011 and which names Richard C. Ewers, John R. Brustad, Edward D. Pingleton, Nabil Hilal, Gary R. Dulak, Payam Adlparvar, and Robert R. Bowes as the inventors. A true and correct copy of the 755 patent is attached hereto as Exhibit A. As the owner, Applied has the right to sue for infringement of the 755 patent. DEFENDANTS INFRINGEMENT OF U.S. PATENT NO. 8,016,755 7. Applied repeats and re-alleges the allegations of paragraphs 1-6 of
this Complaint as if set forth fully herein. 8. Defendant infringes, both directly and indirectly, one or more
claims of the 755 patent, in violation of 35 U.S.C. 271, by making, using, offering for sale, selling, and/or importing products marketed by Defendant as a SILS Port, and also by marketing and promoting the SILS Port and related products for use in what Defendant promotes as SILS Procedures. 9. The SILS Port is a surgical access device suitable for, inter alia,
performing laparoscopic surgical procedures with one or more instruments passing through the device and through a single incision in an abdominal wall of a patient with the abdominal cavity pressurized with an insufflation gas. 10. The SILS Port surgical access device is adapted to provide
instrument access to the abdominal cavity for surgical procedures while generally maintaining insufflation pressure in the abdominal cavity of a patient. 11. material. 12. On information and belief, the SILS Port surgical access device is The SILS Port surgical access device is formed of an elastomeric
formed of a material comprising a triblock copolymer. 13. On information and belief, the SILS Port surgical access device is
formed of a material comprising an oil. 14. On information and belief, the SILS Port surgical access device is
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
15.
The SILS Port surgical access device has an external flange and an
internal flange integrally formed with the device. 16. The SILS Port surgical access device with flanges is formed
monolithically. 17. The external flange of the SILS Port surgical access device is
adapted to be disposed external to the abdominal wall of a patient in an operative position and the internal flange of the device is adapted to be disposed internal to the abdominal wall in the operative position, wherein the device is configured to be maintained in the operative position and adapted to form a seal with the abdominal wall. 18. The SILS Port surgical access device has one or more openings
between an external surface and an internal surface of the device, the openings when operatively disposed are in communication with an incision in a patients abdominal wall and form a working channel between a location external to the abdominal wall and a location internal to the abdominal wall. 19. The SILS Port surgical access device is adapted to conform to a
surface of an instrument inserted through the working channel, at least a portion of the device between the external flange and the internal flange and within an incision in a patients abdominal wall between an external surface of the abdominal wall and an internal surface of the abdominal wall is adapted to form an instrument seal with the instrument. 20. The SILS Port surgical access device is adapted to be located
within an incision in a patients abdominal wall and create a radially compressive force to provide an axial seal between the device and the abdominal wall. 21. Defendants acts of infringement are undertaken without
permission or license from Applied. 22. Applied is informed and believes, and thereon alleges, that -3-
Exhibit A -6-
Exhibit A -7-
Exhibit A -8-
Exhibit A -9-
Exhibit A -10-
Exhibit A -11-
Exhibit A -12-
Exhibit A -13-
Exhibit A -14-
Exhibit A -15-
Exhibit A -16-
Exhibit A -17-
Exhibit A -18-
Exhibit A -19-
Exhibit A -20-
Exhibit A -21-
Exhibit A -22-
Exhibit A -23-
Exhibit A -24-
Exhibit A -25-
Exhibit A -26-
Exhibit A -27-
Exhibit A -28-
Exhibit A -29-
Exhibit A -30-
Exhibit A -31-
Exhibit A -32-
Exhibit A -33-
Exhibit A -34-
Exhibit A -35-
Exhibit A -36-
Exhibit A -37-
Exhibit A -38-
Exhibit A -39-
Exhibit A -40-
Exhibit A -41-